Biologics
The annual business revenue of the biomedical industry in Binhai is expected to reach 100 billion yuan ($15.44 billion) by 2025 with the ...
October 01, 2021 | News
Cynata Therapeutics Limited (ASX: "CYP" or "Cynata"), a clinical-stage biotechnology company specialising in cell therapeutics, has today an...
October 01, 2021 | News
Partnership will broaden global access for scientists to benefit from portable DNA/RNA sequencing technology that provides rich data in real time, for life...
September 28, 2021 | News
- Study finds improved seizure control and positive outcomes in 75 percent of patients with actionable genetic findings that led to clinical management cha...
September 27, 2021 | News
GenScript ProBio grants a non-exclusive global license to AskGene to use GenScript ProBio's sdAb targeting immune checkpoint target for disc...
September 27, 2021 | News
Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, w...
September 24, 2021 | News
The Citeline Awards were created to recognize accomplishments across the biopharmaceutical industry, providing an opportunity for the industry to honor its...
September 24, 2021 | News
Providence grants Everest license to develop and market potentially "Best-In-Class" mRNA COVID-19vaccine for select Asia territories Provid...
September 15, 2021 | News
Data show the vaccine regimen induced neutralizing antibody responses in nearly all participating adults and children 21 days after the second dose Adults...
September 14, 2021 | News
FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturing, under accelerated timelines, for NeuExcell'...
September 13, 2021 | News
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to establish a manufacturing facility in Nashvil...
September 10, 2021 | News
This latest fund represents a significant expansion of the principal investment business of RMG, building on the team's 25-plus year history in life scienc...
September 08, 2021 | News
The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product g...
September 07, 2021 | News
FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the treatment of acute myeloid leukemia (AML) patients in complete remission. FLYSYN wa...
September 06, 2021 | News
Most Read
Bio Jobs
News